Author

SoberanaPlus

The Phase II clinical trials of Soberana Plus in convalescents of COVID 19 will include 450 people and will broaden the inclusion criteria compared to Phase I, informed today an expert from the Finlay Vaccine Institute (IFV), the entity that developed this vaccine candidate against COVID-19.

ensayo clinico soberana pedriatica The first 25 teenagers included in Cuba's Soberana-Pediatrics anti-Covid-19 clinical trial received Monday the dose of the Soberana Plus vaccine candidate to conclude the vaccination scheme announced the leaders of the project.

The Company of the Biotechnology and Pharmaceutical Industry and the Center for Genetic Engineering and Biotechnology were declared on Wednesday the first two High Technology institutions in Cuba. Read more Cuban authorities declare leading biotechnology companies

The University of Holguín is strengthening the links with the sugar company AZCUBA of the province from the planning of various scientific projects aimed at materializing the economic and productive objectives of the entity in the cultivation of cane. Read more Holguín University Strengthens Links with Sugar Companies

Diaz Canel Vietnam Speech delivered by Miguel Mario Díaz-Canel Bermúdez, First Secretary of the Central Committee of the Communist Party of Cuba and President of the Republic, on the occasion of the 65th Anniversary of bilateral relations between Cuba and Vietnam, at the Ho Guom Theater, Hanoi, Vietnam, on September 1, 2025, "Year 67 of the Revolution".

Page 386 of 479

Phase II clinical trial of vaccine candidate Soberana Plus to include 450 COVID 19 convalescents

Soberana-Pediatrics clinical trial advances with the third dose in Cuba

Cuban authorities declare leading biotechnology companies

Holguín University Strengthens Links with Sugar Companies

Vietnam's extraordinary history of resistance and victories is at the foundation of our exemplary ties

More Articles